Loading...
CSIG-23. miR-146a PREDICTS BETTER OVERALL SURVIVAL AND ACTS AS A TEMOZOLOMIDE (TMZ) SENSITIZER THROUGH TARGETING MULTIPLE SIGNALING PATHWAYS IN GLIOBLASTOMA
BACKGROUND: Glioblastomas (GBMs) are the most aggressive primary brain tumors, with an average survival of less than 15 months. microRNAs (miRNAs) are emerging as promising, novel prognostic biomarkers in GBM. miRNA-146a acts as a tumor suppressor in different cancer types. This purpose of this stud...
Na minha lista:
| Udgivet i: | Neuro Oncol |
|---|---|
| Main Authors: | , , , , , , , , , , , |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
Oxford University Press
2018
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6216673/ https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/neuonc/noy148.189 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|